[Basic research and drug development for arteriosclerosis obliterans].
Takahashi
Kenzo
K
kenzo.takahashi@po.rd.taisho.co.jp
D043924:Angiogenesis Modulating Agents / Q000627:therapeutic use; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D006801:Humans
D043924:Angiogenesis Modulating Agents